
Iron May Rain From Sand Clouds on Newly-Discovered Planet
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
Dusty clouds made of sand—that may rain iron—blanket a giant planet orbiting a young, sun-like star just 310 light-years from Earth, the James Webb Space Telescope has revealed.
The discovery was made by an international team of astronomers led from the Space Telescope Science Institute (STScI) in Baltimore Maryland.
Around the star—dubbed "YSES-1"—the researchers also directly observed another giant exoplanet around which is a potentially multiple-moon-forming circumplanetary disk.
"This work highlights the incredible abilities of JWST to characterize exoplanet atmospheres," said paper author and astronomer Evert Nasedkin of Trinity College Dublin, Ireland, in a statement.
"With only a handful of exoplanets that can be directly imaged, the YSES-1 system offers unique insights into the atmospheric physics and formation processes of these distant giants."
An artist's impression of the planets of the star system YSES-1.
An artist's impression of the planets of the star system YSES-1.
Ellis Bogat
Using Webb's Near InfraRed Spectrograph (NIRSpec), the team were able to capture the two planets—which are both several times larger than Jupiter, and orbit out far from their host star—in a single exposure.
This has provided what lead author and STScI physicist Kielan Hoch calls "the most detailed dataset of a multi-planet system to date."
Nasedkin added: "Directly imaged exoplanets—planets outside our own solar system—are the only exoplanets that we can truly take photos of.
"These exoplanets are typically still young enough that they are still hot from their formation—and it is this warmth, seen in the thermal infrared, that we as astronomers observe."
By recording the light coming from the two exoplanets, the team were able to unpick the signals that reveal the chemical makeup of the gas giant's atmospheres.
"When we looked at the smaller, farther-out companion—known as YSES-1c—we found the tell-tale signature of silicate clouds in the mid-infrared," said Nasedkin.
"Essentially made of sand-like particles, this is the strongest silicate absorption feature observed in an exoplanet yet."
The team's analysis also indicated that the clouds contain iron, which may fall from the clouds down into the planet as rain.
"We believe this is linked to the relative youth of the planets: younger planets are slightly larger in radius, and this extended atmosphere may allow the cloud to absorb more of the light emitted by the planet."
The circumplanetary disk is the inner planet, YSES-1b, meanwhile, presents something of a mystery.
Only three other such disks have been identified to date, but they are all around objects that are significantly younger than YSES-1b—leading to questions as to how the newly discovered disk could be so long-lived.
And that is far from the only puzzle that will need to be solved.
"The YSES-1 system planets are also too widely separated to be explained through current formation theories, so the additional discoveries of distinct silicate clouds around YSES-1c and small hot dusty material around YSES-1b leads to more mysteries and complexities for determining how planets form and evolve," Hoch concluded.
Do you have a tip on a science story that Newsweek should be covering? Do you have a question about exoplanets? Let us know via science@newsweek.com.
Reference
Hoch, K. K. W., Rowland, M., Petrus, S., Nasedkin, E., Ingebretsen, C., Kammerer, J., Perrin, M., D'Orazi, V., Balmer, W. O., Barman, T., Bonnefoy, M., Chauvin, G., Chen, C., De Rosa, R. J., Girard, J., Gonzales, E., Kenworthy, M., Konopacky, Q. M., Macintosh, B., Moran, S. E., Morley, C. V., Palma-Bifani, P., Pueyo, L., Ren, B., Rickman, E., Ruffio, J.-B., Theissen, C. A., Ward-Duong, K., & Zhang, Y. (2025). Silicate clouds and a circumplanetary disk in the YSES-1 exoplanet system. Nature. https://doi.org/10.1038/s41586-025-09174-w
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Weight-loss jabs could help obese people control asthma, study suggests
Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a potential treatment for obese people with the respiratory condition, who are 'often resistant' to steroids, researchers said. Weight-loss jabs, also known as glucagon-like peptide1 receptor-agonists (GLP1-RAs), work by mimicing the hormone GLP-1 to regulate blood sugar and insulin levels. They were initially developed as a treatment for people with type 2 diabetes. A number of types of the drug are recommended to help tackle obesity on the NHS, including semaglutide, or Wegovy, and tirzepatide, or Mounjaro. Previous studies have suggested the drugs may slash the risk of illnesses like dementia and stroke, with an international team of experts exploring their potential impact on obese people with asthma. Professor David Price, University of Aberdeen chair in primary care respiratory medicine, said: 'People with obesity and asthma are unique in that they are often resistant to steroid treatments. 'We know that GLP1s work on inflammatory responses in the airways in a different way to traditionally used steroids.' For the study, published in Advances in Therapy, researchers analysed the records of 10,111 people on GLP1-RAs and 50,555 people who were not on the drugs. After a follow-up period, the team found that those taking weight-loss jabs lost more weight and had improved asthma control. Researchers said the findings suggest medics 'should pay attention to the relationship between GLP-1 RA and the risk of respiratory diseases'. Prof Price added: 'We found compelling evidence that GLP1s, as well as increasing weight loss, also improved asthma symptoms. 'In addition, it is important to note that the benefits to asthma symptoms occurred despite fairly modest weight loss of around 0.9kg over the course of the year. 'Our findings suggest that GLP1s may have beneficial effects on asthma control for people with obesity and this should be explored further.' Prof Alan Kaplan, chairperson of the Family Physician Airways Group of Canada and the Observational and Pragmatic Research Institute, said: 'Our findings suggest that GLP1-RAs have benefits on asthma control in people with obesity, and this information should contribute to the discussions around the decision to use these drugs.' Dr Erika Kennington, head of research and innovation at Asthma and Lung UK, said: 'Research has previously shown that people living with obesity who lose weight see improved control of their asthma, so it's encouraging to see this study show this is still the case when the weight loss is driven by drugs, like the new class of weight loss drugs. 'Although exercise can help people lose weight, for some people it can cause anxiety about becoming breathless or having an asthma attack, so people are stuck in a vicious cycle of not being able to lose weight and their asthma worsening. 'Therefore, where exercise hasn't worked for someone these drugs that support weight loss could offer a promising alternative. 'It's too early to say whether these drugs would be effective for people with asthma more widely. 'More research is needed to understand how these drugs actually improve asthma control. Funding for lung health research is on life support and urgent action is needed to increase investment.'


New York Post
9 hours ago
- New York Post
Mounjaro boobs? Weight loss drug can shrink breast cancer tumors, says new study
Turns out that GLP-1 drugs aren't just slimming waistlines — they're shrinking tumors, too. A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting injected with tirzepatide, which is sold as Mounjaro for diabetes and Zepbound for obesity. 'Obesity is a significant risk factor for breast cancer,' said study author Amanda Kucinskas, a Ph.D. candidate at the University of Michigan. 4 Breast cancer is the most commonly diagnosed cancer in women worldwide, excluding skin cancers. okrasiuk – 'And while it is very preliminary data, our studies in mice suggest that these new anti-obesity drugs may be a way to reduce obesity-associated breast cancer risk or improve outcomes.' Tirzepatide is part of a class of GLP-1 drugs, like Ozempic and Wegovy, that reduce appetite by mimicking the GLP-1 hormone the body naturally produces after eating. Tirzepatide also mimics the effects of GIP, a gut hormone that stimulates insulin release and influences fat storage and appetite. For the new study, 16 young mice with breast cancer were fattened up and kept in a warm home to encourage obesity. 4 Tirzepatide is sold as Mounjaro for diabetes and Zepbound for obesity. K KStock – The mice were then given tirzepatide or a placebo every other day for 16 weeks. The researchers measured their tumor volumes twice a week, finding that as the mice shed the pounds and the fat stored in their livers, their tumors shrank accordingly. The findings were presented this month at ENDO 2025, the Endocrine Society's annual meeting. 'While these are very preliminary results, they suggest that this new anti-obesity drug may also have a beneficial impact on breast cancer outcomes,' Kucinskas said. 4 A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting injected with tirzepatide. romaset – Breast cancer is the most commonly diagnosed cancer in women worldwide, besides skin cancer. One in eight American women will likely be diagnosed with it at some point. There are several reasons why obesity is a major risk factor for breast cancer. 'Obesity causes widespread inflammation throughout the entire body, deregulating the balance of cell growth patterns, body defenses and the gut microbiome,' Dr. Sue Decotiis — an NYC-based medical weight loss doctor, who was not involved in the new study — told The Post. 'Even a modest reduction of fat could have an important anti-inflammatory effect.' Excess abdominal fat can also lead to higher estrogen levels. Hormonal imbalances promote breast cancer development, Decotiis said. Plus, obesity is often associated with higher-than-normal levels of insulin in the blood, which can stimulate the production of estrogen in fat tissue. 'In my clinical weight loss practice, all secondary benefits from GLP-1 drugs occurred in patients who lost not weight, but a significant reduction in fat,' Decotiis said. 4 Obesity is a major risk factor for breast cancer, particularly in postmenopausal women. Choi_ Nikolai – Although GLP-1 meds have been hailed as 'wonder drugs,' there are risks associated with them. Side effects can include gastrointestinal distress and, less often, hair loss and skin pain. Blindness and behavioral changes can occur in very rare cases. Decotiis noted that tirzepatide is often better tolerated than the other meds because it can cause less nausea and vomiting while also spurring more weight loss. Meanwhile, research continues on the potential for these drugs to slow the progression of Alzheimer's disease, improve sleep apnea, reduce alcohol cravings and treat liver disease, among other conditions. 'Hold on to your hats and buckle up as this category of drug grows and we see more of their wide range of positive effects and learn more about their mechanisms,' Decotiis said.


Newsweek
11 hours ago
- Newsweek
Massive Great White Shark Pings Off Nantucket Coast: Track Its Movements
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A colossal great white shark recently surfaced off the coast of New England — and has continued to lurk along the Atlantic coastline this summer, researchers said. The 13-foot-9-inch specimen, dubbed "Contender," weighs 1,653 pounds, marking the largest male white shark ever tagged in the western Atlantic by OCEARCH, a nonprofit marine research organization. The apex predator, first tagged in January roughly 45 miles off the Florida-Georgia coast, surfaced again last Friday about 50 miles east of Nantucket, Massachusetts, between Nantucket Shoals and Georges Bank. His beacon has not pinged since. Known as "Contender," researchers say the largest male white shark they ever tagged in the western Atlantic recently pinged off the coast of Nantucket, Massachusetts. Known as "Contender," researchers say the largest male white shark they ever tagged in the western Atlantic recently pinged off the coast of Nantucket, Massachusetts. OCEARCH "Contender's second ping on July 18 shows that he's now about 62 miles east of Nantucket Island," OCEARCH data scientist John Tyminski told Newsweek in a statement Thursday. "This movement north is typical for white sharks at this time of year — they're on their northern migration to their summer-fall foraging areas." Western North Atlantic white sharks predominantly utilize two relatively broad regions during summer and fall months, Cape Cod and Atlantic Canada, he said. "Both of these areas have healthy populations of seals which can be a rich food source especially for larger white sharks like Contender," Tyminski explained, although white sharks will also opportunistically feed on various types of fish, squid and other marine mammals. The shark, named in honor of longtime OCEARCH partner Contender Boats, had previously pinged just 22 miles off the coast of Cape Hatteras, North Carolina, researchers said in early June. Prior to last week's ping, the massive great white has been spotted off the coast of Cape Hatteras, North Carolina, in early June, researchers said. Prior to last week's ping, the massive great white has been spotted off the coast of Cape Hatteras, North Carolina, in early June, researchers said. OCEARCH "The Outer Banks is a common rest stop for these white sharks," an OCEARCH staffer wrote on Instagram. "And Contender appears to be doing just that — taking a rest. This may be due to rich food resources in this region, and it would serve as a time to feed and prepare before what may be a long journey of 1,000 miles or more up to Canada." A ping is emitted when tags attached to dorsal fins rise above the surface, transmitting real-time location data to researchers. OCEARCH has tagged 446 animals to date, according to the group's website. Visitors can track Contender and other ocean predators on OCEARCH's global shark tracker. Adult male great white sharks in the western Atlantic like Contender typically range between 11 and 13 feet, researchers said. Adult male great white sharks in the western Atlantic like Contender typically range between 11 and 13 feet, researchers said. OCEARCH "The SPOT tag deployed on Contender will provide valuable real-time data for approximately five years, helping us track his movements and understand his migration patterns," according to OCEARCH's page that monitors the shark. "Additionally, we've collected important biological samples, including urogenital material, which are currently being analyzed." While Contender represents the largest Atlantic male white shark ever to be tagged by OCEARCH, a 17-foot-2-inch female white shark named Nukumi retains the title as the largest specimen OCEARCH has ever tagged and released, Tyminski told Newsweek. Nukumi, named after a Native American mythological figure, was first tagged off Lunenberg, Nova Scotia, in October 2020 and weighed 3,541 pounds. Her last ping was transmitted in 2021, data shows. White sharks have an estimated maximum size of about 20 feet, with unconfirmed reports of some reaching up to 23 feet in length, according to the Florida Museum of Natural History. "The white shark has been credited with more fatal attacks on humans than any other species of shark," the museum's website reads. "This is due primarily to its size, power and feeding behavior."